5-LOX Inhibitor Zileuton Reduces Inflammatory Reaction and Ischemic Brain Damage Through the Activation of PI3K/Akt Signaling Pathway.
about
Changes in transcranial electrical motor-evoked potentials during the early and reversible stage of permanent spinal cord ischemia predict spinal cord injury in a rabbit animal model.The phosphatidylinositide 3-kinase (PI3K) signaling pathway is a determinant of zileuton response in adults with asthma.LY294002, a PI3K inhibitor, attenuates Tourette syndrome in rats.
P2860
5-LOX Inhibitor Zileuton Reduces Inflammatory Reaction and Ischemic Brain Damage Through the Activation of PI3K/Akt Signaling Pathway.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
5-LOX Inhibitor Zileuton Reduc ...... of PI3K/Akt Signaling Pathway.
@en
5-LOX Inhibitor Zileuton Reduc ...... of PI3K/Akt Signaling Pathway.
@nl
type
label
5-LOX Inhibitor Zileuton Reduc ...... of PI3K/Akt Signaling Pathway.
@en
5-LOX Inhibitor Zileuton Reduc ...... of PI3K/Akt Signaling Pathway.
@nl
prefLabel
5-LOX Inhibitor Zileuton Reduc ...... of PI3K/Akt Signaling Pathway.
@en
5-LOX Inhibitor Zileuton Reduc ...... of PI3K/Akt Signaling Pathway.
@nl
P2093
P2860
P1476
5-LOX Inhibitor Zileuton Reduc ...... of PI3K/Akt Signaling Pathway.
@en
P2093
Chun-Hua Wang
Chun-Mei Chen
Hua-Bin Zhang
Ri-Sheng Liang
Song-Sheng Shi
Wei-Zhong Yang
Xian-Kun Tu
P2860
P2888
P304
P356
10.1007/S11064-016-1994-X
P577
2016-07-05T00:00:00Z